ACP
AMGN icon

Argyle Capital Partners’s Amgen AMGN Stock Holding History

Argyle Capital Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.62M Sell
4,597
-299
-6% -$107K 1.16% 24
2025
Q4 		$1.6M Sell
4,896
-667
-12% -$212K 1.17% 22
2025
Q3 		$1.57M Buy
5,563
+509
+10% +$148K 1.13% 24
2025
Q2 		$1.41M Sell
5,054
-126
-2% -$35.7K 1.16% 23
2025
Q1 		$1.61M Sell
5,180
-141
-3% -$41.6K 1.38% 18
2024
Q4 		$1.39M Buy
+5,321
New +$1.58M 1.19% 23

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Argyle Capital Partners's AMGN Position: Q1 2026 in Review

Argyle Capital Partners reduced its Amgen (AMGN) stake by 6.1% in Q1 2026, selling an estimated $107K and leaving 4,597 shares worth $1.62M. The position accounts for 1.16% of the portfolio, ranked #24.

Argyle Capital Partners first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Argyle Capital Partners held 4,597 shares of Amgen worth $1.62M as of Q1 2026.
  • Argyle Capital Partners sold 299 Amgen shares in Q1 2026, an estimated $107K.
  • Amgen made up 1.16% of Argyle Capital Partners's portfolio in Q1 2026, its #24 holding.
  • Argyle Capital Partners first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Argyle Capital Partners's 13F filing for Q1 2026, filed 7 May 2026.